Approval · Notice of Compliance 26540 · 2021
UVADEX: Notice of Compliance 26540
Issued August 31, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26540
- Date
- August 31, 2021
- Company
- Therakos IncBridgewater, New Jersey, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Product Monograph; and Removal of all referrals to UVAR XTS electrophoresis system based on discontinuation of the medical device from use in Canada.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| UVADEX | Not yet assigned | — |
Medicinal ingredients
- METHOXSALEN 20 MCG per ML